Company: RGNT
Filing Date: 2025-01-27
Form Type: DRS/A
Source: 0001213900-25-006676
Chunk: 157

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-01-27
Form: DRS/A
Chunk 157
---
 required under the Nasdaq Stock Market rules. See “Management—Board Practices—Approval of Related Party Transactions under Israeli Law” for additional information.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |

| ● | Annual Shareholders Meeting.  As opposed to the Nasdaq Stock Market Rule 5620(a), which mandates that a listed company hold its annual shareholders meeting within one year of the company’s fiscal year-end, we are required, under the Companies Law, to hold an annual shareholders meeting each calendar year and within 15 months of the last annual shareholders meeting.                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| ● | Distribution of periodic reports to shareholders; proxy solicitation. As opposed to the Nasdaq Stock Market rules, which require listed issuers to make such reports available to shareholders in one of a number of specific manners, Israeli law does not require us to distribute periodic reports directly to shareholders, and the generally accepted business practice in Israel is not to distribute such reports to shareholders but to make such reports available through a public website. In addition to making such reports available on a public website, we currently make our audited consolidated financial statements available to our shareholders at our offices and will only mail such reports to shareholders upon request. As a foreign private issuer, we are generally exempt from the SEC’s proxy solicitation rules. |

<div align='center'>95</div>

Foreign Private Issuer

Under
the Companies Law, companies incorporated under the laws of the State of Israel whose shares are publicly traded, including
companies with shares listed on the Nasdaq Capital Market, are considered public companies under Israeli law and are required to
comply with various corporate governance requirements under Israeli law relating to matters such as external directors, the audit
committee, the compensation committee and an internal auditor. This is the case even if our shares are not listed on a stock
exchange in Israel. These requirements are in addition to the corporate governance requirements imposed by the Listing Rules of the
Nasdaq Capital Market, or the Nasdaq Marketplace Rules, and other applicable provisions of U.S. securities laws to which we are
subject (as a foreign private issuer).

Board Practices

Introduction

Our
amended and restated articles of association to be in effect upon completion of this offering provide that we may have between five (5)
and eight (8) directors, including directors who serve as external directors under the Companies Law. Immediately as of the effective
time of the registration statement to which this prospectus relates, our board of directors will consist of